Literature DB >> 27729674

Zafirlukast: Chronic Urticaria.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2015        PMID: 27729674      PMCID: PMC5057193          DOI: 10.1310/hpj5010-873

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  4 in total

Review 1.  The diagnosis and management of acute and chronic urticaria: 2014 update.

Authors:  Jonathan A Bernstein; David M Lang; David A Khan; Timothy Craig; David Dreyfus; Fred Hsieh; Javed Sheikh; David Weldon; Bruce Zuraw; David I Bernstein; Joann Blessing-Moore; Linda Cox; Richard A Nicklas; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Diane E Schuller; Sheldon L Spector; Stephen A Tilles; Dana Wallace
Journal:  J Allergy Clin Immunol       Date:  2014-05       Impact factor: 10.793

2.  The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results.

Authors:  Scott E Bagenstose; Linda Levin; Jonathan A Bernstein
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

3.  Zafirlukast has no beneficial effects in the treatment of chronic urticaria.

Authors:  A Reimers; C Pichler; A Helbling; W J Pichler; N Yawalkar
Journal:  Clin Exp Allergy       Date:  2002-12       Impact factor: 5.018

4.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.